Corteva has completed a spinoff of its seed business into Vylor, shifting its strategy toward crop chemicals. JPMorgan upgraded the stock to overweight with a $19 price target, implying 53% upside potential. Analyst Jeffrey Zekauskas views the valuation as attractive, noting that new in-licensed crop chemical molecules should deliver strong growth and above-average margins. Corn prices, which recovered to around $5 per bushel after falling below $4, could support pricing stability or improvement in the sector by 2027. Of the 23 analysts covering the stock, 15 recommend buy or strong buy, and shares have gained 23% year to date despite declining 6% in the past month.
Source: Read the original article
Disclaimer: this content is for information purposes only and is not financial advice. Cryptocurrencies are highly volatile: you may lose all of your capital. Always do your own research. Legal notice
